Literature DB >> 709967

[A big family of paralysis agitans (author's transl)].

H Nukada, H Kowa, T Saitoh, Y Tazaki, S Miura.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 709967

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN： 0009-918X


× No keyword cloud information.
  6 in total

Review 1.  LRRK2 in Parkinson disease: challenges of clinical trials.

Authors:  Eduardo Tolosa; Miquel Vila; Christine Klein; Olivier Rascol
Journal:  Nat Rev Neurol       Date:  2020-01-24       Impact factor: 42.937

2.  Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.

Authors:  Kazuko Hasegawa; A Jon Stoessl; Teruo Yokoyama; Hisayuki Kowa; Zbigniew K Wszolek; Saburo Yagishita
Journal:  Parkinsonism Relat Disord       Date:  2008-09-18       Impact factor: 4.891

Review 3.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 4.  Molecular genetics of Parkinson's disease: Contributions and global trends.

Authors:  Manabu Funayama; Kenya Nishioka; Yuanzhe Li; Nobutaka Hattori
Journal:  J Hum Genet       Date:  2022-07-11       Impact factor: 3.755

Review 5.  Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells.

Authors:  Liesel Goveas; Eugénie Mutez; Marie-Christine Chartier-Harlin; Jean-Marc Taymans
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

Review 6.  Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.

Authors:  Matthew Taylor; Dario R Alessi
Journal:  Curr Opin Cell Biol       Date:  2020-02-07       Impact factor: 8.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.